49,294
edits
Difference between revisions of "Hepatocyte nuclear factor-1beta"
Jump to navigation
Jump to search
Hepatocyte nuclear factor-1beta (view source)
Revision as of 21:07, 2 January 2025
, 21:07, 2 January 2025+bladder
(+bladder) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 13: | Line 13: | ||
*[[Prostate adenocarcinoma]].<ref name=pmid30065837/> | *[[Prostate adenocarcinoma]].<ref name=pmid30065837/> | ||
*Gastroesophageal adenocarcinoma.<ref name=pmid30065837/> | *Gastroesophageal adenocarcinoma.<ref name=pmid30065837/> | ||
*Bladder urothelial carcinoma ~40% positive.<ref>{{cite journal |authors=Yang MX, Coates RF, Ambaye A, Gardner JA, Zubarick R, Gao Y, Skelly J, Liu JG, Mino-Kenudson M |title=Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma |journal=Biomark Res |volume=6 |issue= |pages=25 |date=2018 |pmid=30065837 |pmc=6062876 |doi=10.1186/s40364-018-0139-6 |url=}}</ref> | |||
==Negative== | ==Negative== | ||
*[[Serous carcinoma of the ovary]]. | |||
*[[Hepatocellular carcinoma]].<ref name=pmid30065837/> | *[[Hepatocellular carcinoma]].<ref name=pmid30065837/> | ||
*[[Colorectal adenocarcinoma]].<ref name=pmid30065837/> | *[[Colorectal adenocarcinoma]].<ref name=pmid30065837/> | ||
*[[Breast adenocarcinoma]].<ref name=pmid30065837/> | *[[Breast adenocarcinoma]].<ref name=pmid30065837/> | ||
*[[Lung squamous cell carcinoma]].<ref name=pmid30065837/> | *[[Lung squamous cell carcinoma]].<ref name=pmid30065837/> | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|2}} | ||
[[Category:Immunohistochemistry]] | [[Category:Immunohistochemistry]] | ||